combination therapy

On target clinical trial success bullseye score
Pharma

Keytruda, Padcev cut risk of death by 50% in MIBC patient subset

The perioperative PD-1/ADC combo also significantly improved event-free survival by 60% versus surgery alone.
Angus Liuu Oct 18, 2025 10:30am
ChatGPT said Low-poly magenta liver model centered on a pale blue background patterned with sketchy dollar signs suggestin

Big Pharma bets big on MASH with a new combo playbook

Oct 17, 2025 9:30am
Combine

Jazz, Roche's small cell lung cancer combo snags FDA approval

Oct 3, 2025 10:00am
AZ

AstraZeneca bolsters Tagrisso's case amid J&J rivalry

Sep 7, 2025 2:15am
Graphic of a dart right on a bullseye sun breaking through the clouds in the background

Padcev-Keytruda combo delivers bladder cancer 'breakthrough'

Aug 12, 2025 11:16am
AZ

AstraZeneca touts life-extension benefit for Tagrisso combo

Jul 21, 2025 2:59pm